Disorder of GPI anchor biosynthesis

MONDO:0024321

A disease that has its basis in the disruption of GPI anchor biosynthetic process.

Also known as: GPI anchor biosynthetic process disease, GPIBD, disorder of GPI anchor biosynthetic process, glycosylphosphatidylinositol biosynthesis defect

76 clinical trials for this condition and its sub-types.

Follow this condition — get notified about new trials

Sub-types

Paroxysmal nocturnal hemoglobinuria (66) CHIME syndrome (0) Developmental and epileptic encephalopathy, 55 (0) Developmental and epileptic encephalopathy, 77 (0) Developmental and epileptic encephalopathy, 80 (0) Glycosylphosphatidylinositol biosynthesis defect 15 (0) Glycosylphosphatidylinositol biosynthesis defect 16 (0) Glycosylphosphatidylinositol biosynthesis defect 17 (0) Glycosylphosphatidylinositol biosynthesis defect 18 (0) Glycosylphosphatidylinositol biosynthesis defect 25 (0) GM3 synthase deficiency (0) Hypercoagulability syndrome due to glycosylphosphatidylinositol deficiency (0) Hyperphosphatasia-intellectual disability syndrome (0) Hyperphosphatasia with intellectual disability syndrome 1 (0) Hyperphosphatasia with intellectual disability syndrome 2 (0) Hyperphosphatasia with intellectual disability syndrome 3 (0) Hyperphosphatasia with intellectual disability syndrome 4 (0) Hyperphosphatasia with intellectual disability syndrome 5 (0) Hyperphosphatasia with intellectual disability syndrome 6 (0) Inborn disorder of glycosphingolipid and glycosylphosphatidylinositol anchor glycosylation (0)

Broader categories

Disease (618) Metabolic disease (215) Human disease (14) Disease by developmental or physiological process (0) Disorder of glycosylation (0)

Trials to join now! 31 Not yet recruiting 6 Not yet finished but already full! 20 Completed 17 Terminated 2

Disorder of GPI anchor biosynthesis

Sub-types

Broader categories

PNH drug iptacopan tested in Real-World setting – but study cut short

BCX9930 safety checked in PNH patients who benefited from treatment